Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlutaPanc II: L-glutamine + Gemcitabine + Nab-paclitaxel in Advanced Pancreatic Cancer
NCT07864571Phase 2Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of glutamine in pancreatic ductal adenocarcinoma (PDAC). Planned start Dec 2026; status: not yet recruiting.
02
Drugs
glutamine
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT07864571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07864571.